GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Biopharmaceuticals Co Ltd (XKRX:326030) » Definitions » 5-Year Yield-on-Cost %

SK Biopharmaceuticals Co (XKRX:326030) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 08, 2024)


View and export this data going back to 2020. Start your Free Trial

What is SK Biopharmaceuticals Co 5-Year Yield-on-Cost %?

SK Biopharmaceuticals Co's yield on cost for the quarter that ended in Mar. 2024 was 0.00.


The historical rank and industry rank for SK Biopharmaceuticals Co's 5-Year Yield-on-Cost % or its related term are showing as below:



XKRX:326030's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.87
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of SK Biopharmaceuticals Co's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, SK Biopharmaceuticals Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SK Biopharmaceuticals Co's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SK Biopharmaceuticals Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where SK Biopharmaceuticals Co's 5-Year Yield-on-Cost % falls into.



SK Biopharmaceuticals Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of SK Biopharmaceuticals Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

SK Biopharmaceuticals Co  (XKRX:326030) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


SK Biopharmaceuticals Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of SK Biopharmaceuticals Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


SK Biopharmaceuticals Co (XKRX:326030) Business Description

Traded in Other Exchanges
N/A
Address
221, Pangyoyeok-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494
SK Biopharmaceuticals Co Ltd is a pharmaceutical company engaged in research and development of new drugs for treatment of central nervous system (CNS) disorders. The company is also researching for the development of drugs to treat brain tumors, including metastatic tumors. It has a Bio Science Research Institute in Pangyo Techno Valley in Gyeonggi Province. Its drugs in pipeline include Cenobamate, Solriamfetol, Carisbamate, Relenopride, SKL13865, SKL20540, SKL-PSY, and SKL24741.

SK Biopharmaceuticals Co (XKRX:326030) Headlines

No Headlines